10.1001/jama.2023.24945
People with longstanding type 2 diabetes often have more advanced beta cell dysfunction and may respond less robustly to GLP-1 therapy
We currently supply the following states: Alaska, Colorado, Connecticut, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Jersey, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin and Wyoming Were adding more locations soon, so if youre interested in our treatments contact us and well do our best to reach you as soon as possible
Results are awaited by January 2023
Mller TD, Finan B, Clemmensen C, et al
These patterns often signal that your current dose is suboptimal, that a different compound would suit your physiology better, or that underlying factorsemotional eating, sleep deprivation, medical conditionsrequire additional support